Zuojin Wan Combined With Woonosan Fumarate for the Treatment of GRD Combined With Depression
Status:
NOT_YET_RECRUITING
Trial end date:
2026-06-30
Target enrollment:
Participant gender:
Summary
To evaluate the improvement of symptoms in patients with gastroesophageal reflux disease combined with depression (hepatic and gastric depression-heat type) by Zuojin Wan combined with vornodine fumarate regimen as a control, and to compare the adherence to the medication and the adverse reactions of the patients between the two groups.
Phase:
NA
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University